SGEN

Seagen, Inc.

1 day chart

About SGEN

Seagen Inc. is a biotechnology company that develops and commercializes targeted therapies to treat cancer. The Company is engaged in commercializing ADCETRIS, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas; PADCEV, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers; TUKYSA, or tucatinib, for the treatment of certain metastatic human epidermal growth factor receptor 2 (HER2) -positive breast and colorectal cancers, and TIVDAK, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers. It is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients. Its programs including ADCETRIS, PADCEV and TIVDAK, are based on the Company’s antibody-drug conjugate (ADC) technology that utilizes the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells.

Buy US stocks in Australia starting with SGEN. Open an account and start investing today!

Market Capitalisation

$36.63B

Price-earnings ratio

Dividend yield

0.00%

Volume

761.95K

High today

$195.88

Low today

$194.00

Open price

$194.12

52-week high

$207.17

52-week low

$116.08

SGEN FAQs

Can I buy SGEN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy SGEN shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Seagen, Inc.?

One share of Seagen, Inc. is valued at $195.42.

What is the ticker symbol for Seagen, Inc.?

The ticker symbol for Seagen, Inc. is SGEN.

How do I buy SGEN shares in Australia?

To buy SGEN stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in SGEN

What is the 52-week high for Seagen, Inc. stock?

The Seagen, Inc. 52-week high stock price is $207.17.

What is the 52-week low for Seagen, Inc. stock?

The Seagen, Inc. 52-week low stock price is $116.08.

What is the market capitalisation of Seagen, Inc. SGEN?

As of 04/06/2023 Seagen, Inc. has a market cap of $37B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.